Chronic cough, a persistent and debilitating condition, poses a significant challenge in clinical practice due to its multifactorial nature. Understanding its complexity and refining diagnostic and management strategies are essential for optimal patient outcomes.
Chronic cough can result from a myriad of conditions including chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), and postnasal drip syndrome. It's crucial to perform a comprehensive clinical assessment, including a detailed history and physical examination, to identify potential causes and guide further diagnostic testing.
A stepwise approach is recommended for diagnosing chronic cough. Initial investigations should focus on common causes, using tests such as spirometry, chest X-ray, and upper airway endoscopy. If these tests are inconclusive, more advanced diagnostic modalities, including high-resolution computed tomography and bronchoscopy, may be warranted. Additionally, empirical therapy trials can be used to diagnose conditions like GERD and asthma, where diagnostic tests may lack sensitivity.
Treatment should be tailored to the underlying cause identified. For example, inhaled corticosteroids may be beneficial in cough-variant asthma, while proton pump inhibitors can be used in GERD-associated cough. In refractory cases, multidisciplinary input may be necessary. Non-pharmacological interventions, such as speech therapy and behavioral techniques, have also shown promise in managing unexplained chronic cough.
Despite advances, chronic cough remains a complex condition with significant diagnostic and therapeutic challenges. Future research should focus on refining diagnostic criteria, developing novel therapeutic agents, and understanding the pathophysiology of unexplained chronic cough. Additionally, more emphasis on patient-centered outcomes and quality of life measures is needed.
Chronic cough represents a complex clinical problem requiring a comprehensive approach for effective diagnosis and management. By refining our understanding and approach, we can improve patient outcomes, reduce healthcare utilization, and advance the field of cough research.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation